InvestorsHub Logo
Followers 2
Posts 1107
Boards Moderated 0
Alias Born 11/10/2006

Re: walldiver post# 2268

Friday, 03/23/2007 1:24:55 AM

Friday, March 23, 2007 1:24:55 AM

Post# of 12660
Sanofi threatened short term because pts will take Provenge first who would otherwise have done Taxotere first. But maybe long term Prov is not so bad for Tax - given the apparent synergy between Provenge and Taxotere, or Provenge's survival effect that keeps more men around for Taxotere? Or do you see better ways than Tax to get the T-cell effect that Prov looks to need?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.